Oral Calcidiol Is More Effective Than Cholecalciferol Supplementation to Reach Adequate 25(OH)D Levels in Patients with Autoimmune Diseases Chronically Treated with Low Doses of Glucocorticoids: A “Real-Life” Study
Glucocorticoids (GCs) are the cornerstone of the therapy in many autoimmune and inflammatory diseases. However, it is well known that their use is a double edged sword, as their beneficial effects are associated almost universally with unwanted effects, as, for example glucocorticoid-induced osteopo...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466436/ https://www.ncbi.nlm.nih.gov/pubmed/26124976 http://dx.doi.org/10.1155/2015/729451 |
_version_ | 1782376213599223808 |
---|---|
author | Ortego-Jurado, Miguel Callejas-Rubio, José-Luis Ríos-Fernández, Raquel González-Moreno, Juan González Ramírez, Amanda Rocío González-Gay, Miguel A. Ortego-Centeno, Norberto |
author_facet | Ortego-Jurado, Miguel Callejas-Rubio, José-Luis Ríos-Fernández, Raquel González-Moreno, Juan González Ramírez, Amanda Rocío González-Gay, Miguel A. Ortego-Centeno, Norberto |
author_sort | Ortego-Jurado, Miguel |
collection | PubMed |
description | Glucocorticoids (GCs) are the cornerstone of the therapy in many autoimmune and inflammatory diseases. However, it is well known that their use is a double edged sword, as their beneficial effects are associated almost universally with unwanted effects, as, for example glucocorticoid-induced osteoporosis (GIO). Over the last years, several clinical practice guidelines emphasize the need of preventing bone mass loss and reduce the incidence of fractures associated with GC use. Calcium and vitamin D supplementation, as adjunctive therapy, are included in all the practice guidelines. However, no standard vitamin D dose has been established. Several studies with postmenopausal women show that maintaining the levels above 30–33 ng/mL help improve the response to bisphosphonates. It is unknown if the response is the same in GIO, but in the clinical practice the levels are maintained at around the same values. In this study we demonstrate that patients with autoimmune diseases, undergoing glucocorticoid therapy, often present suboptimal 25(OH)D levels. Patients with higher body mass index and those receiving higher doses of glucocorticoids are at increased risk of having lower levels of 25(OH)D. In these patients, calcidiol supplementations are more effective than cholecalciferol to reach adequate 25(OH)D levels. |
format | Online Article Text |
id | pubmed-4466436 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-44664362015-06-29 Oral Calcidiol Is More Effective Than Cholecalciferol Supplementation to Reach Adequate 25(OH)D Levels in Patients with Autoimmune Diseases Chronically Treated with Low Doses of Glucocorticoids: A “Real-Life” Study Ortego-Jurado, Miguel Callejas-Rubio, José-Luis Ríos-Fernández, Raquel González-Moreno, Juan González Ramírez, Amanda Rocío González-Gay, Miguel A. Ortego-Centeno, Norberto J Osteoporos Research Article Glucocorticoids (GCs) are the cornerstone of the therapy in many autoimmune and inflammatory diseases. However, it is well known that their use is a double edged sword, as their beneficial effects are associated almost universally with unwanted effects, as, for example glucocorticoid-induced osteoporosis (GIO). Over the last years, several clinical practice guidelines emphasize the need of preventing bone mass loss and reduce the incidence of fractures associated with GC use. Calcium and vitamin D supplementation, as adjunctive therapy, are included in all the practice guidelines. However, no standard vitamin D dose has been established. Several studies with postmenopausal women show that maintaining the levels above 30–33 ng/mL help improve the response to bisphosphonates. It is unknown if the response is the same in GIO, but in the clinical practice the levels are maintained at around the same values. In this study we demonstrate that patients with autoimmune diseases, undergoing glucocorticoid therapy, often present suboptimal 25(OH)D levels. Patients with higher body mass index and those receiving higher doses of glucocorticoids are at increased risk of having lower levels of 25(OH)D. In these patients, calcidiol supplementations are more effective than cholecalciferol to reach adequate 25(OH)D levels. Hindawi Publishing Corporation 2015 2015-06-01 /pmc/articles/PMC4466436/ /pubmed/26124976 http://dx.doi.org/10.1155/2015/729451 Text en Copyright © 2015 Miguel Ortego-Jurado et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Ortego-Jurado, Miguel Callejas-Rubio, José-Luis Ríos-Fernández, Raquel González-Moreno, Juan González Ramírez, Amanda Rocío González-Gay, Miguel A. Ortego-Centeno, Norberto Oral Calcidiol Is More Effective Than Cholecalciferol Supplementation to Reach Adequate 25(OH)D Levels in Patients with Autoimmune Diseases Chronically Treated with Low Doses of Glucocorticoids: A “Real-Life” Study |
title | Oral Calcidiol Is More Effective Than Cholecalciferol Supplementation to Reach Adequate 25(OH)D Levels in Patients with Autoimmune Diseases Chronically Treated with Low Doses of Glucocorticoids: A “Real-Life” Study |
title_full | Oral Calcidiol Is More Effective Than Cholecalciferol Supplementation to Reach Adequate 25(OH)D Levels in Patients with Autoimmune Diseases Chronically Treated with Low Doses of Glucocorticoids: A “Real-Life” Study |
title_fullStr | Oral Calcidiol Is More Effective Than Cholecalciferol Supplementation to Reach Adequate 25(OH)D Levels in Patients with Autoimmune Diseases Chronically Treated with Low Doses of Glucocorticoids: A “Real-Life” Study |
title_full_unstemmed | Oral Calcidiol Is More Effective Than Cholecalciferol Supplementation to Reach Adequate 25(OH)D Levels in Patients with Autoimmune Diseases Chronically Treated with Low Doses of Glucocorticoids: A “Real-Life” Study |
title_short | Oral Calcidiol Is More Effective Than Cholecalciferol Supplementation to Reach Adequate 25(OH)D Levels in Patients with Autoimmune Diseases Chronically Treated with Low Doses of Glucocorticoids: A “Real-Life” Study |
title_sort | oral calcidiol is more effective than cholecalciferol supplementation to reach adequate 25(oh)d levels in patients with autoimmune diseases chronically treated with low doses of glucocorticoids: a “real-life” study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466436/ https://www.ncbi.nlm.nih.gov/pubmed/26124976 http://dx.doi.org/10.1155/2015/729451 |
work_keys_str_mv | AT ortegojuradomiguel oralcalcidiolismoreeffectivethancholecalciferolsupplementationtoreachadequate25ohdlevelsinpatientswithautoimmunediseaseschronicallytreatedwithlowdosesofglucocorticoidsareallifestudy AT callejasrubiojoseluis oralcalcidiolismoreeffectivethancholecalciferolsupplementationtoreachadequate25ohdlevelsinpatientswithautoimmunediseaseschronicallytreatedwithlowdosesofglucocorticoidsareallifestudy AT riosfernandezraquel oralcalcidiolismoreeffectivethancholecalciferolsupplementationtoreachadequate25ohdlevelsinpatientswithautoimmunediseaseschronicallytreatedwithlowdosesofglucocorticoidsareallifestudy AT gonzalezmorenojuan oralcalcidiolismoreeffectivethancholecalciferolsupplementationtoreachadequate25ohdlevelsinpatientswithautoimmunediseaseschronicallytreatedwithlowdosesofglucocorticoidsareallifestudy AT gonzalezramirezamandarocio oralcalcidiolismoreeffectivethancholecalciferolsupplementationtoreachadequate25ohdlevelsinpatientswithautoimmunediseaseschronicallytreatedwithlowdosesofglucocorticoidsareallifestudy AT gonzalezgaymiguela oralcalcidiolismoreeffectivethancholecalciferolsupplementationtoreachadequate25ohdlevelsinpatientswithautoimmunediseaseschronicallytreatedwithlowdosesofglucocorticoidsareallifestudy AT ortegocentenonorberto oralcalcidiolismoreeffectivethancholecalciferolsupplementationtoreachadequate25ohdlevelsinpatientswithautoimmunediseaseschronicallytreatedwithlowdosesofglucocorticoidsareallifestudy |